70th Scientific Sessions of the American Heart Association

A H Jan Danser1, C A van Kesteren, A MaassenVanDenbrink

  • 1Department of Pharmacology, Room EE1418b, Erasmus University, Dr. Molewaterplein 50, 3015 GE Rotterdam, The Netherlands.

Insights

The 70th Scientific Sessions of the American Heart Association featured 4,300 abstracts from 13,103 submissions. These findings on cardiovascular research were presented to 37,000 attendees, including 21,000 medical professionals.

Area of Science:

  • Cardiology
  • Medical Conferences

Background:

  • The American Heart Association (AHA) Scientific Sessions is a premier global event for cardiovascular science.
  • This conference serves as a critical platform for disseminating cutting-edge research and fostering collaboration among healthcare professionals.

Purpose of the Study:

  • To summarize the scope and scale of the 70th Scientific Sessions of the American Heart Association.
  • To highlight the significant volume of research presented and the broad attendance of medical professionals.

Main Methods:

  • The 70th Scientific Sessions of the AHA convened with a large international audience.
  • A rigorous selection process identified 4,300 abstracts from over 13,000 submissions for presentation.
  • Abstracts were published in a supplement to the journal Circulation.

Main Results:

  • The conference attracted 37,000 attendees, comprising 21,000 medical professionals.
  • A total of 4,300 abstracts were selected for presentation, representing a fraction of the 13,103 submissions.
  • The proceedings are accessible via a supplement in Circulation.

Conclusions:

  • The 70th AHA Scientific Sessions successfully gathered a substantial number of medical professionals and presented a significant body of cardiovascular research.
  • The publication of abstracts in Circulation ensures the wide dissemination of presented findings within the medical community.

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...